{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:39:11Z","timestamp":1793133551432,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>In cystic fibrosis, abnormal glucose tolerance is associated with decreased lung function and worsened outcomes. Translational evidence indicates that abnormal glucose tolerance may begin in early life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether very young children with cystic fibrosis have increased abnormal glucose tolerance prevalence compared with control subjects. The secondary objective was to compare area under the curve for glucose and insulin in children with cystic fibrosis with control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective multicenter study in children ages 3 months to 5 years with and without cystic fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Oral glucose tolerance testing with glucose, insulin, and C-peptide was sampled at 0, 10, 30, 60, 90, and 120 minutes. Twenty-three children with cystic fibrosis and nine control subjects had complete data. All control subjects had normal glucose tolerance. Nine of 23 subjects with cystic fibrosis had abnormal glucose tolerance (39%; P\u2009=\u20090.03). Of those, two met criteria for cystic fibrosis\u2013related diabetes, two indeterminate glycemia, and six impaired glucose tolerance. Children with cystic fibrosis failed to exhibit the normal increase in area under the curve insulin with age observed in control subjects (P\u2009&amp;lt;\u20090.01), despite increased area under the curve glucose (P\u2009=\u20090.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Abnormal glucose tolerance is notably prevalent among young children with cystic fibrosis. Children with cystic fibrosis lack the normal increase in insulin secretion that occurs in early childhood despite increased glucose. These findings demonstrate that glycemic abnormalities begin very early in cystic fibrosis, possibly because of insufficient insulin secretion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201512-2518oc","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T13:01:39Z","timestamp":1469192499000},"page":"974-980","source":"Crossref","is-referenced-by-count":102,"title":["Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis"],"prefix":"10.1093","volume":"194","author":[{"given":"Yaling","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Anatomy and Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Norris","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Fraternal Order of Eagles Diabetes Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliye","family":"Uc","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology"},{"name":"Fraternal Order of Eagles Diabetes Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Larson","family":"Ode","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Fraternal Order of Eagles Diabetes Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"key":"2026032023561884600_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/adc.2011.300710","article-title":"What are the main research findings during the last 5 years that have changed my clinical practice in diabetes medicine?","volume":"97","author":"Gregory","year":"2012","journal-title":"Arch Dis Child"},{"key":"2026032023561884600_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc09-1215","article-title":"Diabetes as a determinant of mortality in cystic fibrosis","volume":"33","author":"Chamnan","year":"2010","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib3","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023561884600_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3476(98)70171-4","article-title":"Abnormal glucose metabolism in cystic fibrosis","volume":"133","author":"Moran","year":"1998","journal-title":"J Pediatr"},{"key":"2026032023561884600_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-5448.2009.00632.x","article-title":"Oral glucose tolerance testing in children with cystic fibrosis","volume":"11","author":"Ode","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"2026032023561884600_bib8","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.2337\/dc12-0459","article-title":"Glucose derangements in very young children with cystic fibrosis and pancreatic insufficiency","volume":"35","author":"Mozzillo","year":"2012","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20140059","article-title":"Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass","volume":"128","author":"Uc","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"2026032023561884600_bib10","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1172\/JCI60610","article-title":"Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets","volume":"122","author":"Olivier","year":"2012","journal-title":"J Clin Invest"},{"key":"2026032023561884600_bib11","first-page":"S216","article-title":"Glucose tolerance in infants and young children with cystic fibrosis: poster session abstracts","volume":"49","author":"Ode","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2026032023561884600_bib12","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"2026032023561884600_bib14","first-page":"280","article-title":"Fibrocystic disease of the pancreas and diabetes in an adult with unusual pulmonary manifestations","volume":"89","author":"Caldwell","year":"1958","journal-title":"Calif Med"},{"key":"2026032023561884600_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(13)70015-9","article-title":"New insights into cystic fibrosis-related diabetes in children","volume":"1","author":"Ode","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026032023561884600_bib16","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"2026032023561884600_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM196908282810901","article-title":"Glucose intolerance in cystic fibrosis","volume":"281","author":"Handwerger","year":"1969","journal-title":"N Engl J Med"},{"key":"2026032023561884600_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"2026032023561884600_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201405-0882LE","article-title":"Resolution of cystic fibrosis-related diabetes with ivacaftor therapy","volume":"190","author":"Hayes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023561884600_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clnu.2011.09.007","article-title":"Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance","volume":"31","author":"Alicandro","year":"2012","journal-title":"Clin Nutr"},{"key":"2026032023561884600_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis","volume":"152","author":"Bismuth","year":"2008","journal-title":"J Pediatr"},{"key":"2026032023561884600_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023561884600_bib23","first-page":"2","article-title":"Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life","volume":"60","author":"Ogilvy-Stuart","year":"2003","journal-title":"Horm Res"},{"key":"2026032023561884600_bib24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/diabetes.50.8.1891","article-title":"Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes","volume":"50","author":"Takano","year":"2001","journal-title":"Diabetes"},{"key":"2026032023561884600_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/eje.0.1400315","article-title":"Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients","volume":"140","author":"Laursen","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2026032023561884600_bib26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2003-031409","article-title":"Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis","volume":"89","author":"Darmaun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026032023561884600_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-10-1003","article-title":"Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients","volume":"165","author":"Battezzati","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026032023561884600_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2007.02.005","article-title":"Increased glucose excursion in cystic fibrosis and its association with a worse clinical status","volume":"6","author":"Costa","year":"2007","journal-title":"J Cyst Fibros"},{"key":"2026032023561884600_bib29","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/jc.2015-1512","article-title":"Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients","volume":"100","author":"Battezzati","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026032023561884600_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2012.10.008","article-title":"Evolution of pancreatic function during the first year in infants with cystic fibrosis","volume":"162","author":"O\u2019Sullivan","year":"2013","journal-title":"J Pediatr"},{"key":"2026032023561884600_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpeds.2009.10.019","article-title":"Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program","volume":"156","author":"Sterescu","year":"2010","journal-title":"J Pediatr"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/194\/8\/974\/67265023\/ajrccm_194_8_974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/194\/8\/974\/67265023\/ajrccm_194_8_974.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:56:27Z","timestamp":1774065387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/194\/8\/974\/8509684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,10,15]]},"published-print":{"date-parts":[[2016,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201512-2518oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,10]]}}}